{
    "root": "342bb8c8-51e9-99b2-e063-6394a90a0391",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "Glipizide",
        "suffix": {
            "text": "ER"
        }
    },
    "value": "20250502",
    "ingredients": [
        {
            "name": "ACETYLTRIBUTYL CITRATE",
            "code": "0ZBX0N59RZ"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)",
            "code": "S38J6RZN16"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "9XZ8H6N6OH"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)",
            "code": "74G4R6TH13"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "GLIPIZIDE",
            "code": "X7WDT95N5C"
        }
    ],
    "indications": "glipizide extended-release tablets indicated adjunct diet exercise improve glycemic control adults type 2 diabetes mellitus .",
    "contraindications": "recommended starting dose 5 mg daily . dose adjustment made based patient ’ glycemic control . maximum recommended dose 20 mg daily ( 2.1 ) . administer breakfast first meal day ( 2.1 ) . combination therapy blood-glucose-lowering agents , initiate agent lowest recommended dose , observe patients hypoglycemia ( 2.2 ) .",
    "warningsAndPrecautions": "glipizide extended-release tablets supplied 5 mg round , unscored , film-coated tablets printed black ink follows : 5 mg tablets orange printed “ wpi ” “ 844 ” . available following package sizes : bottles 7 ndc 55289-779-07 bottles 30 ndc 55289-779-30 bottles 90 ndc 55289-779-90 store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . protect moisture humidity .",
    "adverseReactions": "glipizide contraindicated patients : known hypersensitivity glipizide product ’ ingredients . hypersensitivity sulfonamide derivatives .",
    "indications_original": "Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
    "contraindications_original": "Recommended starting dose is 5 mg once daily. Dose adjustment can be made based on the patient’s glycemic control. Maximum recommended dose is 20 mg once daily ( 2.1 ). Administer with breakfast or the first meal of the day ( 2.1 ). For combination therapy with other blood-glucose-lowering agents, initiate the agent at the lowest recommended dose, and observe patients for hypoglycemia ( 2.2 ).",
    "warningsAndPrecautions_original": "Glipizide Extended-Release Tablets are supplied as 5 mg round, unscored, film-coated tablets and are printed with black ink as follows:\n                  5 mg tablets are orange and printed with “ \n  WPI” and “ \n  844”. They are available in the following package sizes:\n  \n                     \nBottles of    7     NDC 55289-779-07\n  \n                     \nBottles of 30      NDC 55289-779-30\n  \n                     \nBottles of 90      NDC 55289-779-90\n \n                  Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture and humidity.",
    "adverseReactions_original": "Glipizide is contraindicated in patients with:\n                  \n                     Known hypersensitivity to glipizide or any of the product’s ingredients.\n                     Hypersensitivity to sulfonamide derivatives."
}